Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06807190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06807190 · ClinicalTrials.gov record · last posted 2026-08-27

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Name: General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus — clinical trial record (NCT06807190)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorNovo Nordisk A/S

Started2025-04-15

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of the study is to investigate the safety and effectiveness of Awiqli in participants with diabetes mellitus under real world clinical practice in Japan. Participants will get Awiqli as prescribed by the study doctor. The study will last for about 1 year.

Protocol amendment history 3 changes detected by DataLookout

2026-08-28

Trial sites expanded: 112 → 116 locations

2026-06-30

Trial sites expanded: 106 → 112 locations

2026-06-06

Trial sites expanded: 80 → 106 locations

Trial Details

NCT Number	NCT06807190
Lead Sponsor	Novo Nordisk A/S
Conditions	Diabetes Mellitus, Type 1
Enrollment	630 participants
Start Date	2025-04-15
Primary Completion	2027-07-31 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-27